Record Information |
---|
Version | 2.0 |
---|
Created at | 2022-03-17 19:19:42 UTC |
---|
Updated at | 2022-03-17 19:19:42 UTC |
---|
NP-MRD ID | NP0045422 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Triacetin |
---|
Description | Triacetin, also known as enzactin or fungacet, belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Thus, triacetin is considered to be a triradylglycerol lipid molecule. Triacetin is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Triacetin is a mild, bitter, and clean tasting compound. Outside of the human body, Triacetin has been detected, but not quantified in, fruits and papaya. This could make triacetin a potential biomarker for the consumption of these foods. Triacetin is found in Carica papay and Vitis vinifera. Triacetin was first documented in 1959 (PMID: 14404545). A triglyceride obtained by acetylation of the three hydroxy groups of glycerol (PMID: 14555416) (PMID: 23293041) (PMID: 23996800) (PMID: 24574778) (PMID: 23340101) (PMID: 22396747). |
---|
Structure | CC(=O)OCC(COC(C)=O)OC(C)=O InChI=1S/C9H14O6/c1-6(10)13-4-9(15-8(3)12)5-14-7(2)11/h9H,4-5H2,1-3H3 |
---|
Synonyms | Value | Source |
---|
1,2,3-Propanetriol triacetate | ChEBI | 1,2,3-Propanetriyl triacetate | ChEBI | 1,2,3-Triacetoxypropane | ChEBI | 1,2,3-Triacetylglycerol | ChEBI | 2-(Acetyloxy)-1-[(acetyloxy)methyl]ethyl acetate | ChEBI | e 1518 | ChEBI | e-1518 | ChEBI | e1518 | ChEBI | Enzactin | ChEBI | Glycerin triacetate | ChEBI | Glycerol triacetate | ChEBI | Glyceryl triacetate | ChEBI | Triacetina | ChEBI | Triacetine | ChEBI | Triacetinum | ChEBI | Triacetyl glycerin | ChEBI | Triacetyl glycerine | ChEBI | Triacetylglycerol | ChEBI | 1,2,3-Propanetriol triacetic acid | Generator | 1,2,3-Propanetriyl triacetic acid | Generator | 2-(Acetyloxy)-1-[(acetyloxy)methyl]ethyl acetic acid | Generator | Glycerin triacetic acid | Generator | Glycerol triacetic acid | Generator | Glyceryl triacetic acid | Generator | 1,2,3-Propanetriol triacetate, 9ci | HMDB | 1,2,3-Propanetriol, 1,2,3-triacetate | HMDB | 1,2,3-Propanetriol, triacetate | HMDB | Acetic, 1,2,3-propanetriyl ester | HMDB | Blekin | HMDB | Enzacetin | HMDB | Estol 1581 | HMDB | Euzactin | HMDB | FEMA 2007 | HMDB | Fungacet | HMDB | Fungacetin | HMDB | Glycerol triacetate tributyrin | HMDB | Glyped | HMDB | Kesscoflex tra | HMDB | Kodaflex triacetin | HMDB | Motisil | HMDB | Propane-1,2,3-triyl triacetate | HMDB | Tri-acetin | HMDB | Triacetin (1,2,3-propanetriol triacetate) | HMDB | Triacetin (glycerol triacetate) | HMDB | Triacetin, 8ci, ban, inn, usan | HMDB | Triacetyl glycerol | HMDB | Vanay | HMDB | Triacetyl-glycerol | HMDB |
|
---|
Chemical Formula | C9H14O6 |
---|
Average Mass | 218.2039 Da |
---|
Monoisotopic Mass | 218.07904 Da |
---|
IUPAC Name | 1,3-bis(acetyloxy)propan-2-yl acetate |
---|
Traditional Name | triacetin |
---|
CAS Registry Number | 102-76-1 |
---|
SMILES | CC(=O)OCC(COC(C)=O)OC(C)=O |
---|
InChI Identifier | InChI=1S/C9H14O6/c1-6(10)13-4-9(15-8(3)12)5-14-7(2)11/h9H,4-5H2,1-3H3 |
---|
InChI Key | URAYPUMNDPQOKB-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded to a glycerol molecule through ester linkages. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Glycerolipids |
---|
Sub Class | Triradylcglycerols |
---|
Direct Parent | Triacylglycerols |
---|
Alternative Parents | |
---|
Substituents | - Triacyl-sn-glycerol
- Tricarboxylic acid or derivatives
- Carboxylic acid ester
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Fiume MZ: Final report on the safety assessment of triacetin. Int J Toxicol. 2003;22 Suppl 2:1-10. [PubMed:14555416 ]
- Choudhury H, Gorain B, Karmakar S, Pal TK: Development and validation of RP-HPLC method: scope of application in the determination of oil solubility of paclitaxel. J Chromatogr Sci. 2014 Jan;52(1):68-74. doi: 10.1093/chromsci/bms206. Epub 2013 Jan 4. [PubMed:23293041 ]
- Tsen AR, Long PM, Driscoll HE, Davies MT, Teasdale BA, Penar PL, Pendlebury WW, Spees JL, Lawler SE, Viapiano MS, Jaworski DM: Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma. Int J Cancer. 2014 Mar 15;134(6):1300-10. doi: 10.1002/ijc.28465. Epub 2013 Sep 30. [PubMed:23996800 ]
- Oosaka K, Tokuda M, Furukawa N: Intra-gastric triacetin alters upper gastrointestinal motility in conscious dogs. World J Gastroenterol. 2014 Jan 28;20(4):1054-60. doi: 10.3748/wjg.v20.i4.1054. [PubMed:24574778 ]
- Goembira F, Saka S: Optimization of biodiesel production by supercritical methyl acetate. Bioresour Technol. 2013 Mar;131:47-52. doi: 10.1016/j.biortech.2012.12.130. Epub 2012 Dec 27. [PubMed:23340101 ]
- Brault G, Shareck F, Hurtubise Y, Lepine F, Doucet N: Isolation and characterization of EstC, a new cold-active esterase from Streptomyces coelicolor A3(2). PLoS One. 2012;7(3):e32041. doi: 10.1371/journal.pone.0032041. Epub 2012 Mar 2. [PubMed:22396747 ]
- KARNS ME, PARKER R: The treatment of refractory fungus infections with fungacetin (triacetin). J Am Podiatry Assoc. 1959 Sep;49:411-2. [PubMed:14404545 ]
- Cheng M, Angkawidjaja C, Koga Y, Kanaya S: Requirement of lid2 for interfacial activation of a family I.3 lipase with unique two lid structures. FEBS J. 2012 Oct;279(19):3727-3737. doi: 10.1111/j.1742-4658.2012.08734.x. Epub 2012 Aug 31. [PubMed:22863357 ]
- Malik B, Benaissa M: Determination of glucose concentration from near-infrared spectra using locally weighted partial least square regression. Annu Int Conf IEEE Eng Med Biol Soc. 2012;2012:6169-71. doi: 10.1109/EMBC.2012.6347402. [PubMed:23367337 ]
- Sarkar B, Ravi V, Alexandridis P: Micellization of amphiphilic block copolymers in binary and ternary solvent mixtures. J Colloid Interface Sci. 2013 Jan 15;390(1):137-46. doi: 10.1016/j.jcis.2012.09.028. Epub 2012 Sep 26. [PubMed:23099248 ]
|
---|